RxSight (RXST) Payables (2020 - 2026)

RxSight (RXST) has 7 years of Payables data on file, last reported at $7.1 million in Q1 2026.

• For the quarter ending Q1 2026, Payables changed 0.18% year-over-year to $7.1 million; the trailing twelve-month figure through Mar 2026 stood at $7.1 million (changed 0.18% YoY), and the FY2025 full-year result was $5.3 million, up 16.55% from the prior year.
• Payables for Q1 2026 stood at $7.1 million, up from $5.3 million in the prior quarter.
• Across five years, Payables topped out at $7.1 million in Q1 2026 and bottomed at $2.6 million in Q1 2022.
• The 5-year median for Payables is $4.1 million (2023), against an average of $4.3 million.
• The widest annual swing landed in 2022, when Payables surged 146.72%; it then tumbled 34.29% in 2025.
• A 5-year view of Payables shows it stood at $2.6 million in 2022, then jumped by 48.86% to $3.9 million in 2023, then grew by 17.63% to $4.5 million in 2024, then gained by 16.55% to $5.3 million in 2025, then jumped by 34.52% to $7.1 million in 2026.
• The last three Payables figures came in at $7.1 million (Q1 2026), $5.3 million (Q4 2025), and $3.4 million (Q3 2025), per Business Quant data.

Peer Comparison